We plan to begin the subject review in October 2022. We will perform this review to meet the reporting requirements of Public Law 105-277, “Office of National Drug Control Policy Reauthorization Act of 1998.” The objective of the review is to attest to the reliability of the assertions made in each of the DoD Detailed Accounting Reports in conformity with the Office of National Drug Control Policy Circular “National Drug Control Program Agency Compliance Reviews,” September 9, 2021.